Literature DB >> 7507176

Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies.

J T Pedersen1, A H Henry, S J Searle, B C Guild, M Roguska, A R Rees.   

Abstract

Statistical analysis of a database of unique human and murine immunoglobulin heavy chain and light chain variable regions reveals that the precise patterns of exposed residues are different in human and murine antibodies, while most individual surface positions have strong preferences for a small number of residue types. Consideration of these surface patterns alone generates almost identical family groupings for light and heavy chain variable domain sequences to those produced by methods such as those of Kabat et al., where N-terminal framework sequences only are compared, or Tomlinson et al., in which entire variable region nucleotide sequences are used. This unexpected result suggests that the surfaces of V-regions are at least as well conserved as the core framework sequences. Furthermore, using these patterns of human and murine surface residues a novel method for the "humanization" of murine antibodies has been developed and tested.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507176     DOI: 10.1006/jmbi.1994.1050

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

Review 2.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

3.  A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries.

Authors:  C Rader; D A Cheresh; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Computationally driven antibody engineering enables simultaneous humanization and thermostabilization.

Authors:  Yoonjoo Choi; Christian Ndong; Karl E Griswold; Chris Bailey-Kellogg
Journal:  Protein Eng Des Sel       Date:  2016-06-21       Impact factor: 1.650

5.  Reduced antibody response to streptavidin through site-directed mutagenesis.

Authors:  D L Meyer; J Schultz; Y Lin; A Henry; J Sanderson; J M Jackson; S Goshorn; A R Rees; S S Graves
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

6.  Humanization of murine monoclonal antibodies through variable domain resurfacing.

Authors:  M A Roguska; J T Pedersen; C A Keddy; A H Henry; S J Searle; J M Lambert; V S Goldmacher; W A Blättler; A R Rees; B C Guild
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.

Authors:  Nives Skrlj; Tanja Vranac; Mara Popović; Vladka Curin Šerbec; Marko Dolinar
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.

Authors:  Sonia Covaceuszach; Sara Marinelli; Ivet Krastanova; Gabriele Ugolini; Flaminia Pavone; Doriano Lamba; Antonino Cattaneo
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

9.  Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.

Authors:  I Benhar; E A Padlan; S H Jung; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 12.779

10.  A novel antibody humanization method based on epitopes scanning and molecular dynamics simulation.

Authors:  Ding Zhang; Cai-Feng Chen; Bin-Bin Zhao; Lu-Lu Gong; Wen-Jing Jin; Jing-Jun Liu; Jing-Fei Wang; Tian-Tian Wang; Xiao-Hui Yuan; You-Wen He
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.